Prism Review Media Group Prism Review Media Group
  • Business
  • Finance
  • Technology
  • Health
  • Culture
Subscribe
Search
Subscribe

Health

Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC
HEALTH

Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC

September 12, 2026

MD Anderson trial challenges local consolidative therapy paradigm in NSCLC
HEALTH

MD Anderson trial challenges local consolidative therapy paradigm in NSCLC

September 12, 2026

Neoadjuvant atezolizumab addition quadruples pathological responses in resectable lung tumors
HEALTH

Neoadjuvant atezolizumab addition quadruples pathological responses in resectable lung tumors

September 12, 2026

Low discontinuation rates confirm manageable safety of iza-bren
HEALTH

Low discontinuation rates confirm manageable safety of iza-bren

September 12, 2026

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination
HEALTH

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

September 12, 2026

In facing the truth of her losses, Sara Bareilles embraces a faith in her own grief
HEALTH

In facing the truth of her losses, Sara Bareilles embraces a faith in her own grief

CNN NEWSOURCE

September 12, 2026

Surprising Benefits of Low Fat Vegan Diet
HEALTH

Surprising Benefits of Low Fat Vegan Diet

KNOWRIDGE

September 12, 2026

Hormone Therapy May Reduce Menopause Mood Symptoms
HEALTH

Hormone Therapy May Reduce Menopause Mood Symptoms

KNOWRIDGE

September 12, 2026

Your Heart May Be Older Than You Think
HEALTH

Your Heart May Be Older Than You Think

KNOWRIDGE

September 12, 2026

Next
Prism Review Media Group

A premium editorial platform for executives, investors, and industry leaders who demand more from their reading. Rigorous journalism. Uncompromising standards.

  • LinkedIn
  • Twitter
  • Instagram
  • YouTube

Categories

  • Business
  • Culture
  • Health
  • Technology

Company

  • About Us
  • Contributors
  • Articles

Quick Links

  • Newsletter
  • Contact
  • Publishing Guidelines
  • Corrections Policy

© 2026 Prism Review Media Group. All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Editorial Policy
  • Cookie Settings